Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer.
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Anti-stathmin gene therapy (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Gradalis; Strike Bio
- 24 Apr 2017 Status changed from active, no longer recruiting to completed.
- 07 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov.
- 07 Apr 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2017, as reported by ClinicalTrials.gov.